Table 2

Estimated kinetic parameters for the formation of Nor, 3F, and 4F from cisapride and UNK from (±)-norcisapride in human liver microsomes or in heterologously expressed P450 enzymes

SampleNor3F4FUNK
Km2-aVmax2-bVmax/Km2-cKm2-aVmax2-bVmax/Km2-cKm2-aVmax2-bVmax/Km2-cKm2-aVmax2-bVmax/Km2-c
H1126.00135022514.369648.713.956840.810725.10.24
H0936.9012518.112.478.06.2914.367.04.68N.D.N.D.N.D.
CYP3A43.20579118104.3016283787.90248031345.549.51.09
CYP3A716.820312.118.116.00.8825.228.71.14N.D.N.D.N.D.
CYP2C82.0010954.53.4028985.05.8026.74.60N.D.N.D.N.D.

H112 and H093 are human liver microsomal samples with high and low CYP3A4/5 activity, respectively.

  • N.D., not determined.

  • 2-a  Micromolar.

  • 2-b  Picomoles per milligram of protein per minute for human liver microsomes, picomoles per nanomole of P450 per minute for cDNA-expressed enzymes.

  • 2-c  Microliters per milligram of protein per minute for human liver microsomes; microliters per nanomole of P450 per minute for cDNA-expressed enzymes.